68Ga-FAPI-RGD PET/CT for Dual Integrin αvβ3 and FAP-targeted Imaging in Patients With Various Types of Cancer and Compared With 18F-FDG
Clinical trial NCT05543317 · COMPLETED
Trial details
- NCT number
- NCT05543317
- Sponsor
- The First Affiliated Hospital of Xiamen University
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-01
- Primary completion
- 2022-12-31
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.